Zou, H., Zhou, B., & Xu, G. (2017). SGLT2 inhibitors: A novel choice for the combination therapy in diabetic kidney disease. Cardiovasc Diabetol.
Chicago Style CitationZou, Honghong, Baoqin Zhou, and Gaosi Xu. "SGLT2 Inhibitors: A Novel Choice for the Combination Therapy in Diabetic Kidney Disease." Cardiovasc Diabetol 2017.
MLA CitationZou, Honghong, Baoqin Zhou, and Gaosi Xu. "SGLT2 Inhibitors: A Novel Choice for the Combination Therapy in Diabetic Kidney Disease." Cardiovasc Diabetol 2017.
Warning: These citations may not always be 100% accurate.